# MedRule — Phase 2: Policy Fidelity Remediation & Validation Summary
**Document Identifier:** `MEDRULE-PHASE2-VALIDATION-SUMMARY`  
**Execution Date:** 2026-10-21  
**Auditor / Engineering Role:** MedRule Prior Authorization Engineering & Deterministic Decision-Tree Architecture  
**Governing Standard:** MedRule Clinical Safety & Zero-Approved Governance Protocol  

---

## 1. Executive Summary

Phase 2 of the MedRule engine development—**Policy Fidelity Remediation and Validation**—has been successfully executed in strict adherence to scope and safety constraints. The audit focused exclusively on verifying the clinical policy content represented by the active rulebook without implementing unauthorized rule modifications, without approving any rules, and without expanding domain scope beyond the two verified clinical specialties: **Advanced Imaging** and **Interventional Pain Management (IPM)**.

### Key Audit Metrics
| Metric | Value | Verification Finding |
| :--- | :--- | :--- |
| **Total Active Clinical Rules** | **128 rules** | 100% accounted for (114 Advanced Imaging, 14 IPM) |
| **Approved Rules Invariant** | **0 rules (0.0%)** | `is_approved == False` unconditionally enforced across registry, database, and engine |
| **Draft Rules** | **121 rules** | Ready for deterministic evaluation testing |
| **Human Review Blocked Rules** | **7 rules** | Unconditionally blocked by `GOVERNANCE_BLOCKED_RULE_IDS` |
| **Partially Verified Rules Audited** | **43 rules** | 100% audited against physical policy PDF pages with proposed corrections |
| **Coverage Gap Records Reconciled** | **204 items** | Deduplicated and classified into 24 distinct topic clusters across 4 policies |
| **New Rule Candidates Identified** | **16 rules** | Discrete clinical policy criteria documented for future Phase 3 authoring |
| **Policy Clarifications Required** | **76 items** | Secondary clinical subsections and advisory phrasing cataloged for SME review |
| **Regression Test Suite** | **29 of 29 passed** | 15 decision tree tests + 14 scope integrity tests passing deterministically |

---

## 2. Baseline Protection & Git Provenance

To guarantee complete baseline recoverability and prevent accidental overwrites, the exact state of the repository prior to Phase 2 remediation was committed, tagged, and branched:

1. **Git Commit Hash:** `e33bea4`  
   - Commit Message: `baseline: deterministic decision-tree implementation, scope cleanup, and policy fidelity audit`
2. **Git Tag:** `baseline-phase2-remediation`
3. **Git Branch:** `baseline-phase2-remediation`
4. **Active Workspace Status:** Verified clean on branch `main`. All 128 active rules in `rulebook_collection/domains/advanced_imaging/rules/draft_rules.json` and `rulebook_collection/domains/interventional_pain_management/rules/draft_rules.json` remain untouched and preserved in their original state.
5. **No Rule Approved:** No rule status was altered to `APPROVED`. All proposed clinical corrections and gap reconciliations are documented strictly within external manifest deliverables.

---

## 3. Audit of the 50 Unresolved Rules

All 50 unresolved rules (7 `HUMAN_REVIEW_REQUIRED` and 43 `PARTIALLY_VERIFIED`) from `rule_policy_fidelity_audit.csv` were inspected against the actual physical pages of the governing policy documents using PDF text extraction tools (`pymupdf`).

### A. The 7 Governance-Blocked Rules (`GOVERNANCE_BLOCKED_RULE_IDS`)
The 7 governance-blocked rules were verified to ensure they cannot execute autonomously:

1. **`RULE-ADV-PREAMBLE-001` (Advanced Imaging Policy, p. 2):**
   - *Policy Standard:* Clinical review determination preamble establishing that determinations are made based on both guidelines and clinical judgment consistent with standards of good medical practice.
   - *Audit Finding:* Draft rule encoded `clinical_information_submitted == true` -> `INDICATED`. This is an overly broad pseudo-rule that would approve any request if notes are attached.
   - *Status:* Affirmed permanently blocked from the deterministic decision tree.

2. **`RULE-IPM-PREAMBLEIPM-001` (IPM Policy, p. 2):**
   - *Policy Standard:* IPM clinical review determination framework.
   - *Audit Finding:* Encoded placeholder parameter `preambleipm_indication IS_PRESENT` -> `INDICATED`. Overly broad non-deterministic clinical judgment statement.
   - *Status:* Affirmed permanently blocked from the deterministic decision tree.

3. **`RULE-ADV-CG2000-003` (Advanced Imaging Policy, p. 9):**
   - *Policy Standard:* Inflammatory Bowel Disease guideline stating: *"includes CT enterography, however, MRI should be considered for age < 35 to reduce radiation exposure"*.
   - *Audit Finding:* Advisory wording was implemented as a mandatory prior authorization denial/redirection (`ALTERNATIVE_MODALITY_RECOMMENDED`).
   - *Status:* Affirmed blocked. Flagged for Medical Director review to determine whether health plan policy mandates redirection or provides an advisory note to the ordering physician.

4. **`RULE-ADV-CG2001-001` (Advanced Imaging Policy, p. 37):**
   - *Policy Standard:* Anti-unbundling note requiring separate requests for CT Abdomen and CT Pelvis involving both regions to be resubmitted under combined codes (74176-74178).
   - *Audit Finding:* Claims unbundling/billing rule conflated with clinical necessity.
   - *Status:* Affirmed blocked from clinical necessity tree; reclassified as an upstream claims pre-processing edit.

5. **`RULE-ADV-CG2066-001` (Advanced Imaging Policy, p. 1036):**
   - *Policy Standard:* Retrospective emergent imaging for conditions impairing airway/breathing/circulation or threatening life/limb.
   - *Audit Finding:* Retrospective emergency evaluation requires qualitative physician review of emergency department charts.
   - *Status:* Affirmed blocked from automated approval; mandatory routing to Physician Review.

6. **`RULE-ADV-CG2066-002` (Advanced Imaging Policy, p. 1036):**
   - *Policy Standard:* Retrospective urgent imaging for conditions requiring intervention within 24 hours to prevent emergency escalation.
   - *Audit Finding:* Subjective 24-hour urgency determination cannot be evaluated autonomously.
   - *Status:* Affirmed blocked from automated approval; mandatory routing to Human Clinical Review.

7. **`RULE-IPM-CGINFUSIONPUMPS-001` (IPM Policy, pp. 68-72):**
   - *Policy Standard:* Intrathecal drug delivery pump insertion criteria requiring >= 12 weeks conservative therapy, psychological evaluation within 12 months, MRSA/MSSA decolonization plan, and temporary trial with >= 50% relief.
   - *Audit Finding:* Draft rule encoded a single placeholder parameter `cginfusionpumps_indication IS_PRESENT`.
   - *Status:* Affirmed blocked until decomposed criteria are authored and clinically validated.

### B. The 43 Partially Verified Rules
The 43 partially verified rules (35 Advanced Imaging, 8 IPM) were cross-referenced against their exact physical PDF pages. All core criteria were verified as clinically accurate, but required remediation for uncodified surrounding policy context:
- **Spine Advanced Imaging (Cervical, Thoracic, Lumbar):** Implemented conservative care thresholds (e.g. `conservative_care_duration_weeks >= 6` in last 6 months) are verified, but policy footnotes specify uncodified red flag exceptions (progressive motor deficit, foot drop, cervical myelopathy, active cancer with back pain) that waive conservative care. Proposed remediations add explicit `ANY_OF` bypass branches.
- **Abdominal/Pelvic CT/CTA:** Implemented acute appendicitis, diverticulitis, and pancreatitis criteria are verified, but omits pregnancy/pediatric ultrasound-first gates and acute surgical contraindications (toxic megacolon, free air perforation).
- **Extremity & Joint CT/MRI:** Knee internal derangement rules require refinement to distinguish acute mechanical locking (immediate MRI) from chronic joint pain (requiring 4-6 weeks conservative care and plain radiographs). Upper extremity CT criteria require restriction to complex bony trauma, redirecting soft tissue derangements to MRI.
- **Interventional Pain Management (IPM):** 8 draft rules used high-level placeholder parameters (e.g. `cgepiduralinjections_indication`). Surrounding policy text on pp. 4-100 contains detailed objective gates: dermatomal radicular pain, MRI correlation, active PT vs home exercise program (HEP), 3-of-5 positive SI provocative maneuvers, dual diagnostic facet blocks, SCS trial duration of 3-7 days with >= 50% relief, and objective sympatholysis monitoring (Horner syndrome, skin temperature differential > 1.5 C).

All findings, verbatim citations, and proposed corrections are documented in [`policy_fidelity_remediation.csv`](file:///d:/PreAuth/rulebook_collection/manifests/policy_fidelity_remediation.csv).

---

## 4. Coverage Gap Reconciliation (204 Records)

The 204 items recorded across `advanced_imaging_coverage_gap_report.csv` (170 items) and `ipm_coverage_gap_report.csv` (34 items) were thoroughly audited to distinguish genuine policy requirements from supporting documents and duplicate records.

### Deduplication and Classification Analysis
The 204 records do **not** represent 204 distinct missing rules. They synthesize into **24 distinct clinical topic clusters**:

```
+----------------------------------------------------------------------------------------------------+
| 204 COVERAGE GAP RECORDS SYNTHESIS                                                                |
+-----------------------------------+-----------------------------------+----------------------------+
| Classification Nature             | Count                             | Proportion                 |
+-----------------------------------+-----------------------------------+----------------------------+
| Genuine Policy Requirements       | 190 items                         | 93.1%                      |
| Supporting Guidance (Tip Sheets)  | 7 items                           | 3.4%                       |
| Non-Applicable Secondary Forms    | 7 items                           | 3.4%                       |
+-----------------------------------+-----------------------------------+----------------------------+
| Existing Rulebook Coverage        | Count                             | Proportion                 |
+-----------------------------------+-----------------------------------+----------------------------+
| Fully Covered by Active Rules     | 98 items                          | 48.0%                      |
| Partially Covered by Active Rules | 16 items                          | 7.8%                       |
| Not Covered in Active Rules       | 90 items                          | 44.1%                      |
+-----------------------------------+-----------------------------------+----------------------------+
| Reconciliation Action             | Count                             | Proportion                 |
+-----------------------------------+-----------------------------------+----------------------------+
| NO_CHANGE (Covered / Non-Gov)     | 112 items                         | 54.9%                      |
| POLICY_CLARIFICATION (Subsections)| 76 items                          | 37.3%                      |
| NEW_RULE (Candidate IPM Rules)    | 16 items                          | 7.8%                       |
+-----------------------------------+-----------------------------------+----------------------------+
```

### Action Breakdown:
1. **`NO_CHANGE` (112 items):**
   - 98 clinical indication sections are already fully codified and evaluated by active verified rules in `draft_rules.json`.
   - 14 items represent secondary provider intake checklists, historical attestation forms, or provider tip sheets that do not supersede governing clinical guidelines.
2. **`POLICY_CLARIFICATION` (76 items):**
   - 70 secondary subsections within established Advanced Imaging guidelines (e.g. specific pulmonary nodule follow-up intervals, pediatric sinus imaging).
   - 5 advisory modality statements requiring Medical Director clarification.
   - 1 Place of Service item (EPOS 1755 pp. 3-6) regarding structured clinical exception criteria for hospital outpatient IPM.
3. **`NEW_RULE` (16 items):**
   - 16 discrete, enforceable clinical criteria sets in Interventional Pain Management that are missing from active rules:
     - Epidural steroid injections for central/lateral spinal stenosis with neurogenic claudication.
     - Repeat injection interval (>= 14 days) and relief duration (>= 50% for >= 6 weeks).
     - Procedural session level limits (max 2 levels for ESI, max 3 for facet blocks).
     - Fluoroscopic guidance mandates and non-coverage of blind injections.
     - Medical contraindications (platelets < 50k, INR > 1.5, systemic infection).
     - Dual comparative diagnostic facet block protocol (>= 50% relief each).
     - Explicit non-coverage of therapeutic intra-articular facet steroid injections.
     - Repeat RFA interval (>= 6 months) with >= 50% relief for >= 6 months (max 2/year).
     - SI joint 3-of-5 positive provocative exam maneuvers (FABER, Gaenslen, distraction, compression, thigh thrust).
     - SI injection annual cap (max 4/year) and 60-day minimum interval.
     - Intraspinal drug infusion pump trial monitoring protocol and psychological clearance.
     - Dorsal Root Ganglion (DRG) stimulation restriction to CRPS lower extremity.
     - SCS generator replacement criteria (battery depletion/malfunction).
     - Anatomically differentiated sympathetic blocks (Stellate, Lumbar, Celiac, Hypogastric, Impar).
     - Objective sympatholytic monitoring criteria (Horner syndrome, skin temperature rise > 1.5 C).

All 204 items are comprehensively cataloged in [`coverage_gap_reconciliation.csv`](file:///d:/PreAuth/rulebook_collection/manifests/coverage_gap_reconciliation.csv).

---

## 5. Review Deliverables Summary

Four authoritative deliverables have been generated and deposited into `rulebook_collection/manifests/` and the workspace root:

1. **[`policy_fidelity_remediation.csv`](file:///d:/PreAuth/rulebook_collection/manifests/policy_fidelity_remediation.csv):**
   - 50 rows detailing every unresolved rule (7 HRR + 43 PV).
   - Contains verbatim policy citations, page numbers, implemented conditions, fidelity gap classifications, verified thresholds, uncodified footnotes, proposed corrections, and clinical review questions.
2. **[`coverage_gap_reconciliation.csv`](file:///d:/PreAuth/rulebook_collection/manifests/coverage_gap_reconciliation.csv):**
   - 204 rows reconciling every reported coverage gap item across Advanced Imaging and IPM.
   - Classifies each item as genuine policy requirement vs supporting guidance vs non-applicable form; documents existing rule coverage; assigns reconciliation actions (`NO_CHANGE`, `POLICY_CLARIFICATION`, `NEW_RULE`); and groups items into 24 deduplicated clusters.
3. **[`human_review_queue.md`](file:///d:/PreAuth/rulebook_collection/manifests/human_review_queue.md):**
   - Structured, prioritized Markdown review queue designed for clinical directors and medical reviewers.
   - Organizes items into 5 clear tiers: Tier 1 (7 Governance-Blocked Rules), Tier 2 (43 Partially Verified Rules across 5 clinical categories), Tier 3 (16 New Rule Candidates), Tier 4 (76 Policy Clarifications), and Tier 5 (14 Secondary Instruments). Includes a formal Medical Director Adjudication Sign-Off Form.
4. **[`policy_validation_summary.md`](file:///d:/PreAuth/rulebook_collection/manifests/policy_validation_summary.md):**
   - This comprehensive synthesis report presenting the methodology, audit findings, gap reconciliation, regression results, and governance invariants.

---

## 6. Regression Testing & Invariant Verification

Following the generation of all audit artifacts, the complete MedRule test suite was executed to verify that no code or rule logic was altered and that all system safeguards remain intact:

```powershell
.venv\Scripts\pytest medrule_engine/tests/test_decision_tree.py rulebook_collection/tests/test_scope_integrity.py
```

### Verification Results
- **Test Results:** **29 passed in 1.42 seconds** (100% pass rate).
- **Rule Inventory Stability:** Exactly 128 active rules verified in registry (114 Advanced Imaging, 14 IPM).
- **Zero Approved Rules Invariant:** 0 rules have `APPROVED` status (`extraction_status == "APPROVED"` is 0; `is_approved == False` for all 128 rules).
- **Governance Blocked Rules:** All 7 blocked rules (`RULE-ADV-PREAMBLE-001`, `RULE-ADV-CG2000-003`, `RULE-ADV-CG2001-001`, `RULE-ADV-CG2066-001`, `RULE-ADV-CG2066-002`, `RULE-IPM-PREAMBLEIPM-001`, `RULE-IPM-CGINFUSIONPUMPS-001`) remain strictly excluded from autonomous decision trees (`GOVERNANCE_BLOCKED_RULE_IDS`).
- **CP.MP.107 Complete Isolation:** Verified that DME/O&P policy CP.MP.107 is not referenced, loaded, or executed in any active evaluation track (`test_15_cp_mp_107_dmepos_complete_isolation_and_non_interference` passed).
- **Historical Document Guard:** Verified that archived/superseded policies cannot enter the active rule registry (`test_08_historical_documents_cannot_silently_enter_active_registry` passed).
- **Source Citation Resolution:** Verified that 100% of physical pages referenced in active rules resolve within the page bounds of their governing PDFs (`test_04_every_referenced_source_page_within_pdf_bounds` passed).
- **Deterministic Repeatability:** Decision tree outcomes execute deterministically without probabilistic variance or LLM dependencies.

---

## 7. Conclusion & Next Steps

Phase 2 Policy Fidelity Remediation and Validation is complete. All 50 unresolved rules and 204 coverage gap items have been audited with strict provenance against authoritative 2026 governing clinical guidelines.

### Boundary of Current Phase:
- **No rules have been modified on disk.**
- **No rules have been promoted to approved.**
- **No clinical validation is claimed.**
- **All proposed corrections are marked for clinical SME and Medical Director review.**

The system is now halted in accordance with prompt instructions, awaiting human clinical review and medical director sign-off on the items in [`human_review_queue.md`](file:///d:/PreAuth/rulebook_collection/manifests/human_review_queue.md).
